ArticleJACC. Asia2025
Impact of Tricuspid Valve Repair on Less Than Moderate Tricuspid Regurgitation After Degenerative Mitral Repair.
Article in JACC. Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Evolving Landscape of Tricuspid Regurgitation Management.JACC. Asia · 2025Article
- Is Less-Than-Moderate Tricuspid Regurgitation in Patients Undergoing Mitral Valve Surgery Always Benign?JACC. Asia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhether tricuspid valve (TV) repair should be performed during degenerative mitral valve repair in patients with less than moderate regurgitation remains controversial.
objectivesThis study aimed to explore the clinical outcomes of degenerative mitral valve repair for less than moderate tricuspid regurgitation (TR).
methodsBetween 2010 and 2019, 541 patients with less than moderate TR underwent mitral valve repair for degenerative mitral disease at the Beijing Anzhen Hospital. Among these patients, 255 underwent concomitant TV repair. The median follow-up was 8 years (Q1-Q3: 6-11 years). The primary endpoint was the development of moderate TR. The secondary endpoint was death, recurrent mitral regurgitation (MR), reoperation for MR or TR, new-onset atrial fibrillation, and permanent pacemaker implantation. Propensity score matching was performed to reduce selection bias.
resultsAfter baseline adjustment, propensity score matching analysis identified 207 pairs. There were no significant differences in the primary endpoints between the patients who underwent simultaneous TV repair and those who did not. Mortality, recurrent MR, permanent pacemaker implantation, and reoperation for MR or TR did not differ significantly between groups. Concomitant TV repair only contributed to new-onset atrial fibrillation, with 24 (11.6%) in the TV-repair group and 7 (3.4%) in the no-repair group (P = 0.001).
conclusionsConsidering its minimal effects on the development of TR and potential contributions to postoperative new-onset atrial fibrillation during follow-up among these patients, more aggressive TV repair is not encouraged among patients with less than moderate TR during MV surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.